<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T08:32:15Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6590556" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6590556</identifier>
        <datestamp>2019-07-07</datestamp>
        <setSpec>neuralplast</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Neural Plast</journal-id>
              <journal-id journal-id-type="iso-abbrev">Neural Plast</journal-id>
              <journal-id journal-id-type="publisher-id">NP</journal-id>
              <journal-title-group>
                <journal-title>Neural Plasticity</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">2090-5904</issn>
              <issn pub-type="epub">1687-5443</issn>
              <publisher>
                <publisher-name>Hindawi</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6590556</article-id>
              <article-id pub-id-type="pmcid">PMC6590556</article-id>
              <article-id pub-id-type="pmc-uid">6590556</article-id>
              <article-id pub-id-type="pmid">31281343</article-id>
              <article-id pub-id-type="doi">10.1155/2019/5857243</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Clinical Study</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The Effect of Combined Patching and Citalopram on Visual Acuity in Adults with Amblyopia: A Randomized, Crossover, Placebo-Controlled Trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lagas</surname>
                    <given-names>Alice K.</given-names>
                  </name>
                  <xref ref-type="aff" rid="I1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Black</surname>
                    <given-names>Joanna M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="I1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Russell</surname>
                    <given-names>Bruce R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="I2">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kydd</surname>
                    <given-names>Robert R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="I3">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3902-2712</contrib-id>
                  <name>
                    <surname>Thompson</surname>
                    <given-names>Benjamin</given-names>
                  </name>
                  <email>ben.thompson@uwaterloo.ca</email>
                  <xref ref-type="aff" rid="I1">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="I4">
                    <sup>4</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="I1"><sup>1</sup>School of Optometry and Vision Science, University of Auckland, New Zealand</aff>
              <aff id="I2"><sup>2</sup>School of Pharmacy, University of Otago, New Zealand</aff>
              <aff id="I3"><sup>3</sup>Department of Psychological Medicine, University of Auckland, New Zealand</aff>
              <aff id="I4"><sup>4</sup>School of Optometry and Vision Science, University of Waterlo, Canada</aff>
              <author-notes>
                <fn fn-type="other">
                  <p>Academic Editor: Malgorzata Kossut</p>
                </fn>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>9</day>
                <month>6</month>
                <year>2019</year>
              </pub-date>
              <volume>2019</volume>
              <elocation-id>5857243</elocation-id>
              <history>
                <date date-type="received">
                  <day>25</day>
                  <month>3</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>14</day>
                  <month>5</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright © 2019 Alice K. Lagas et al.</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Nonhuman animal models have demonstrated that selective serotonin reuptake inhibitors (SSRIs) can enhance plasticity within the mature visual cortex and enable recovery from amblyopia. The aim of this study was to test the hypothesis that the SSRI citalopram combined with part-time patching of the fellow fixing eye would improve amblyopic eye visual acuity in adult humans. Following a crossover, randomized, double-blind, placebo-controlled design, participants completed two 2-week blocks of fellow fixing eye patching. One block combined patching with citalopram (20 mg/day) and the other with a placebo tablet. The blocks were separated by a 2-week washout period. The primary outcome was change in amblyopic eye visual acuity. Secondary outcomes included stereoacuity and electrophysiological measures of retinal and cortical function. Seven participants were randomized, fewer than our prespecified sample size of 20. There were no statistically significant differences in amblyopic eye visual acuity change between the active (mean ± SD change = 0.08 ± 0.16 logMAR) and the placebo (mean change = −0.01 ± 0.03 logMAR) blocks. No treatment effects were observed for any secondary outcomes. However, 3 of 7 participants experienced a 0.1 logMAR or greater improvement in amblyopic eye visual acuity in the active but not the placebo blocks. These results from a small sample suggest that larger-scale trials of SSRI treatment for adult amblyopia may be warranted. Considerations for future trials include drug dose, treatment duration, and recruitment challenges. This study was preregistered as a clinical trial (<ext-link ext-link-type="uri" xlink:href="https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=343135">ACTRN12611000669998</ext-link>).</p>
              </abstract>
              <funding-group>
                <award-group>
                  <funding-source>Canadian Institutes of Health Research</funding-source>
                  <award-id>CIHR 365136</award-id>
                </award-group>
                <award-group>
                  <funding-source>Marsden Fund</funding-source>
                </award-group>
              </funding-group>
            </article-meta>
          </front>
          <body>
            <sec id="sec1">
              <title>1. Introduction</title>
              <p>Disruptions to binocular vision such as strabismus (an eye turn) or anisometropia (unequal refractive error between the two eyes) during the critical period of visual development can cause a neurodevelopmental disorder of vision called amblyopia [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. The deficits associated with amblyopia encompass a wide range of monocular and binocular visual functions [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>] and also extend to the fellow fixing eye [<xref rid="B5" ref-type="bibr">5</xref>]. Clinically, amblyopia is typically diagnosed on the basis of a monocular visual acuity loss that cannot be explained by ocular pathology combined with an amblyogenic factor [<xref rid="B1" ref-type="bibr">1</xref>]. Current treatments for amblyopia in childhood involve the provision of refractive correction followed by patching or penalization of the fellow fixing eye to promote use of the amblyopic eye. These treatments are effective [<xref rid="B6" ref-type="bibr">6</xref>–<xref rid="B12" ref-type="bibr">12</xref>], but efficacy appears to decline with increasing age in children [<xref rid="B13" ref-type="bibr">13</xref>–<xref rid="B16" ref-type="bibr">16</xref>], possibly due to a decline in neural plasticity as the visual cortex matures and exits the critical period for visual development [<xref rid="B17" ref-type="bibr">17</xref>–<xref rid="B20" ref-type="bibr">20</xref>]. A growing body of literature demonstrates that vision can improve in adult humans with amblyopia through interventions such as monocular [<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>] and binocular [<xref rid="B23" ref-type="bibr">23</xref>–<xref rid="B27" ref-type="bibr">27</xref>] perceptual learning and noninvasive brain stimulation [<xref rid="B28" ref-type="bibr">28</xref>–<xref rid="B32" ref-type="bibr">32</xref>]. However, these approaches have not yet translated into positive randomized clinical trials in adult patients that are required for evidence-based clinical practice [<xref rid="B33" ref-type="bibr">33</xref>].</p>
              <p>Amblyopia also forms the basis of a prominent nonhuman animal model for studying cortical development and plasticity [<xref rid="B34" ref-type="bibr">34</xref>]. Monocular amblyopia can be induced in nonhuman animals within the critical period of visual development using an eyelid suture, induction of strabismus, or provision of anisometropic refractive error [<xref rid="B35" ref-type="bibr">35</xref>]. Over the past decade or so, a considerable number of studies have used this model to explore postcritical period neuroplasticity [<xref rid="B36" ref-type="bibr">36</xref>]. Successful interventions for amblyopia recovery in postcritical period animal models include dark exposure [<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>], enriched visual environments [<xref rid="B39" ref-type="bibr">39</xref>], food restriction [<xref rid="B40" ref-type="bibr">40</xref>], binocular training [<xref rid="B41" ref-type="bibr">41</xref>], physical exercise [<xref rid="B42" ref-type="bibr">42</xref>], and retinal inactivation [<xref rid="B43" ref-type="bibr">43</xref>].</p>
              <p>Pharmaceutical interventions have also been investigated in rodent models of amblyopia. A particularly striking result was reported by Vetencourt et al. [<xref rid="B44" ref-type="bibr">44</xref>] whereby chronic administration of the selective serotonin reuptake inhibitor (SSRI) fluoxetine enabled recovery of normal visual cortex responses and visual acuity in mature rats with unilateral deprivation amblyopia. This effect occurred when fluoxetine was administered before and during eyelid suture of the nondeprived eye and opening of the deprived eye (a procedure known as a reverse suture). The improvements in visual function were linked to reduced GABA-mediated inhibition within the visual cortex and increased expression of brain-derived neurotrophic factor (BDNF). This finding is of particular interest in the context of amblyopia treatment in adult humans because SSRIs are widely available to clinicians. Furthermore, SSRIs may enhance plasticity within the human motor [<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>] and visual [<xref rid="B47" ref-type="bibr">47</xref>] cortexes. Fluoxetine has also been found to enhance physiotherapy outcomes after stroke, possibly by increasing cortical plasticity [<xref rid="B48" ref-type="bibr">48</xref>]. However, fluoxetine did not enhance visual perceptual learning of a motion discrimination task or motor cortex plasticity in a study of healthy human adults [<xref rid="B49" ref-type="bibr">49</xref>].</p>
              <p>Two studies have investigated the use of fluoxetine to treat human amblyopia. Sharif et al. [<xref rid="B50" ref-type="bibr">50</xref>] compared 3 months of fellow fixing eye patching plus fluoxetine (0.5 mg/kg/day, <italic>n</italic> = 20) to patching plus a placebo tablet placebo (<italic>n</italic> = 15) in older children and adults (10-40 years) with amblyopia. A significantly greater amblyopic eye visual acuity improvement in the fluoxetine compared to the placebo group was observed. However, Huttunen et al. [<xref rid="B51" ref-type="bibr">51</xref>] found no differences in visual function improvement between a group of adults with amblyopia treated for 10 days with combined perceptual learning and fluoxetine (20 mg per day, <italic>n</italic> = 22) and a group treated with perceptual learning combined with a placebo tablet (<italic>n</italic> = 20).</p>
              <p>In this study, we explored the effects of 2 weeks (14 days) of the SSRI citalopram combined with fellow fixing eye patching on visual acuity, stereopsis, and visually evoked retinal and cortical responses in adults with amblyopia. We anticipated that recruitment would be challenging due to the use of patching and the administration of an antidepressant drug. We therefore adopted a placebo-controlled, randomized, double-blind, crossover design. In this context, citalopram was chosen over fluoxetine (as used in prior studies) because citalopram has a shorter half-life [<xref rid="B52" ref-type="bibr">52</xref>] that allowed for a manageable washout period to be incorporated into the design of the study. No significant effects of citalopram were observed, although our study may have been underpowered due to recruitment challenges.</p>
            </sec>
            <sec id="sec2">
              <title>2. Methods</title>
              <sec id="sec2.1">
                <title>2.1. Trial Design</title>
                <p>The single-site trial involved two blocks of fellow fixing eye patching each lasting two weeks separated by a two-week washout period. Participants were provided with citalopram (1 × 20 mg tablet per day) during one patching block and otherwise identical placebo tablets (sucrose) during the other block. Block order was randomized using a random number generator. The timing of the baseline and the outcome measures are shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Only the pharmacist dispensing the tablets, who did not interact with study participants, was unmasked to block order. Study participants and all other members of the research team were masked to the randomization. The study was approved by the Northern X Regional Ethics Committee in New Zealand (NTX/11/06/044) and preregistered as a clinical trial (<ext-link ext-link-type="uri" xlink:href="https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=343135">ACTRN12611000669998</ext-link>).</p>
                <p>Participants completed a screening protocol consisting of a telephone interview followed by a full optometric examination, medical history, the Profile of Mood States Short Form (POMS-SF) questionnaire, and the Depression Anxiety and Stress Scale (DASS-21).</p>
                <p>Study inclusion criteria were as follows: 18 years of age or over, 0.2 logMAR or worse visual acuity in the amblyopic eye, 0.0 logMAR or better visual acuity in the fellow fixing eye, an interocular acuity difference of at least 0.2 logMAR, and the presence of a strabismus and/or anisometropia defined as a difference in spherical equivalent refractive error of 1.5 dioptres or greater between the eyes. The exclusion criteria were as follows: the presence of ocular pathology, an explanation for the visual acuity loss other than amblyopia, personal or family history of a mood disorder, diabetes, history of addiction, current use of medications or supplements known to alter mood, medications that interact with SSRIs such as codeine, and abnormal mood states evident on the mood questionnaires as reviewed by a psychiatrist. Prior to randomization, participants who were not wearing optimal full correction for both eyes were provided with full correction (either spectacles or contact lenses) and were reviewed every four weeks until visual acuity was stable (&lt;0.2 logMAR difference between visits). Participants were recruited through the University of Auckland Optometry Clinic, referral from eye care practitioners, word of mouth, and newspaper advertisements. Participants were compensated for their time.</p>
              </sec>
              <sec id="sec2.2">
                <title>2.2. Baseline and Outcome Measures</title>
                <p>Visual acuity (VA) was assessed using a computerized ETDRS chart (Medmont) from 6 m. The right eye was tested first. Each correctly identified letter was worth 0.02 logMAR. Binocular vision was assessed using a unilateral cover test, a prism cover test, the Worth 4-dot test (33 cm and 6 m), and the TNO stereoacuity test. Electrophysiological measurements of retinal and visual cortex function were made using ISCEV-standardized electrophysiological protocols on a Roland RETIscan system (software version 4.13.1.8). The following tests were applied monocularly (right eye first): pattern ERG (1° check size—modified from the 0.8° standard for direct comparison with the VEP stimuli), VEP (1° and 0.3° check sizes), and multifocal ERG with pupil dilation. ERG measures were included so that any retinal effects of citalopram could be accounted for if the trial was positive. The POMS-SF questionnaire was completed at each study visit, and participants completed a patching diary for each 2-week patching session. The brain-derived neurotrophic factor (BNDF) phenotype has been identified as a possible mediator of cortical plasticity [<xref rid="B53" ref-type="bibr">53</xref>], and BNDF upregulation has been identified as a mechanism for increased visual cortex plasticity following fluoxetine administration in rats [<xref rid="B44" ref-type="bibr">44</xref>]. To test for BDNF polymorphisms, participants provided a blood sample directly after the first two-week block of patching. Following a previously reported protocol [<xref rid="B49" ref-type="bibr">49</xref>], an Agena MassARRAY iPLEX assay (Agena Bioscience, San Diego, CA, USA) was used for genotyping. A Bruker Mass Spectrometer with optimized parameters for iPLEX chemistry was then used to resolve single base extensions. Typer 4 analysis software (Agena Bioscience) enabled visual inspection of generated peaks in comparison to the nontemplate control.</p>
              </sec>
              <sec id="sec2.3">
                <title>2.3. Statistical Analysis</title>
                <p>At the time of study initiation, no previous studies of SSRIs in human amblyopia treatment were available. Therefore, we selected a sample size of 20 based on recruitment estimates for the study site. Outcome measures were analysed separately using mixed ANOVAs with within-subject factors of Session (baseline vs. outcome) and Treatment (active vs. placebo) and a between-subject factor of Group (active first vs. placebo first).</p>
              </sec>
            </sec>
            <sec id="sec3">
              <title>3. Results</title>
              <p>Sixty-one participants expressed interest in the study and were sent a study information package. Twenty-eight participants responded and were assessed for eligibility. Seven participants were randomized. The CONSORT diagram for these participants is shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>. Reasons for exclusion included time commitment too great, medical or recreational use of drugs, vision too good in the amblyopic eye, and diabetes. One participant who did not meet the visual acuity inclusion criteria was randomized (P6, see <xref rid="tab1" ref-type="table">Table 1</xref>). Data from this participant were included in the final analysis due to the small sample size. Randomized participant details, including BDNF polymorphism, are shown in <xref rid="tab1" ref-type="table">Table 1</xref>.</p>
              <p>Baseline and outcome data for amblyopic eye visual acuity are shown in <xref rid="tab2" ref-type="table">Table 2</xref>. There was no significant interaction between the Session and Treatment factors (<italic>F</italic><sub>1,5</sub> = 1.7, <italic>p</italic> = 0.25, and partial <italic>η</italic><sup>2</sup> = 0.26) indicating no difference between the active and the placebo treatment. The Session factor also had no main effect indicating the absence of a visual acuity improvement across the two periods of patching (<italic>F</italic><sub>1,5</sub> = 1.7, <italic>p</italic> = 0.25, and partial <italic>η</italic><sup>2</sup> = 0.26). Overall, no main effects or interactions were significant in the analysis (all <italic>p</italic> &gt; 0.25). An inspection of individual data (<xref rid="tab2" ref-type="table">Table 2</xref>) indicated that 3/7 participants improved by &gt;0.1 logMAR in the active but not the placebo condition. One of these participants had a val66met BDNF polymorphism. The remaining two had val/val BNDF polymorphisms. No main effects or interactions were present for the fellow fixing eye visual acuity data (all <italic>F</italic> &lt; 3.9, all <italic>p</italic> &gt; 0.1, and all partial <italic>η</italic><sup>2</sup> &lt; 0.4).</p>
              <p>Adherence data are shown in <xref rid="tab3" ref-type="table">Table 3</xref>. Adherence did not differ significantly between active and placebo blocks (<italic>t</italic><sub>6</sub> = 1.0, <italic>p</italic> = 0.9). On average, participants had approximately 70% adherence with the 120 minutes per day of prescribed patching. There was no correlation between patching adherence and visual acuity change in either the active (<italic>r</italic><sub>7</sub> = −0.2, <italic>p</italic> = 0.6) or placebo (<italic>r</italic><sub>7</sub> = 0.3, <italic>p</italic> = 0.5) blocks.</p>
              <p>Only participant P6 exhibited a change in stereoacuity, improving from nil to 240 arc/sec in the active block and from nil to 480 arc/sec in the placebo block. Follow-up stereoacuity was nil. No significant treatment effects were evident for any of the electrophysiological measurements (all <italic>F</italic> &lt; 2.0, all <italic>p</italic> &gt; 2). <xref ref-type="fig" rid="fig3"> Figure 3</xref> shows 1° check stimulus VEP latencies (left) and N75-P100 amplitudes (right) for both the amblyopic and fellow fixing eyes. <xref ref-type="fig" rid="fig4"> Figure 4</xref> shows example multifocal ERG data for participant P7 (first baseline measure), and <xref ref-type="fig" rid="fig5">Figure 5</xref> shows example pattern ERG and VEP data for the same participant. There were no treatment effects on POM-SF scores.</p>
            </sec>
            <sec id="sec4">
              <title>4. Discussion</title>
              <p>The SSRI fluoxetine enabled recovery of vision in mature rats with amblyopia [<xref rid="B44" ref-type="bibr">44</xref>] and has recently been reported to enhance the effect of patching in older children and adults [<xref rid="B50" ref-type="bibr">50</xref>]. We found no effect of the SSRI citalopram combined with two weeks of patching on amblyopic eye visual acuity or a range of secondary outcome measures in adults with amblyopia. These results are broadly consistent with another recent study with a similar duration treatment period (10 days) that reported no advantage of combining fluoxetine with perceptual learning compared to perceptual learning alone in adults with amblyopia [<xref rid="B51" ref-type="bibr">51</xref>]. A preliminary study of donepezil [<xref rid="B54" ref-type="bibr">54</xref>] and a randomized clinical trial of levodopa [<xref rid="B55" ref-type="bibr">55</xref>] have also found no benefit of drug treatment in amblyopia therapy. In addition, we found no effect of two weeks of patching alone in adult patients despite reasonable self-reported adherence. This is expected based on the short treatment period and the reduced effect of patching with increasing age [<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B56" ref-type="bibr">56</xref>].</p>
              <p>A number of factors may explain the lack of a drug treatment effect in our study. First, and perhaps most importantly, we did not achieve our planned sample size of 20 participants due to difficulties with recruitment. This led to a small sample with varied amblyopia etiology and treatment history. Barriers to recruitment included the time commitment required by the study and the stringent medical inclusion criteria. Therefore, our study may be underpowered to detect a treatment effect, although the sample size is within the range of previous case-series perceptual learning studies that have reported treatment effects [<xref rid="B57" ref-type="bibr">57</xref>]. It is intriguing that three participants exhibited an amblyopic eye visual acuity improvement of 0.1 logMAR or greater for the active but not the placebo treatment sessions. These participants had relatively poor baseline amblyopic eye visual acuity compared to most of the other participants. No participants exhibited any improvement for the placebo sessions. This observation suggests that further testing of SSRI treatment effects in adults with amblyopic may be warranted.</p>
              <p>Whereas previous studies have used fluoxetine, we used citalopram because it has a short lead-in period of two hours [<xref rid="B58" ref-type="bibr">58</xref>]. Moreover, citalopram has a shorter half-life than fluoxetine; the distribution phase lasts about ten hours and the terminal half-life (T1/2) is 30-35 hours for citalopram [<xref rid="B58" ref-type="bibr">58</xref>] in contrast to two to four days' half-life for fluoxetine [<xref rid="B59" ref-type="bibr">59</xref>]. Citalopram and fluoxetine appear to have the same efficacy for treating major depression [<xref rid="B60" ref-type="bibr">60</xref>] and comparable effects on plasma GABA, glutamine, and glutamate levels in human patients [<xref rid="B61" ref-type="bibr">61</xref>]. However, citalopram and fluoxetine have different patterns of binding affinity within the human brain [<xref rid="B62" ref-type="bibr">62</xref>]. It is currently unknown whether the two drugs differ in the extent to which they promote visual cortex plasticity.</p>
              <p>We used a 20 mg/day dose of citalopram over 2 weeks. It is possible that larger doses and longer treatment times are required to replicate the effects found in nonhuman animals. Supporting this idea, Sharif et al. [<xref rid="B50" ref-type="bibr">50</xref>] found a significant effect of combined fluoxetine and patching with a dose of 0.5 mg/kg/day and a 3-month treatment period whereas Huttunen et al. [<xref rid="B51" ref-type="bibr">51</xref>] found no effect with 20 mg per day over 10 days. The parameter space for dosing and treatment duration is large for drug intervention studies of this type, and further work is required to identify optimal values. In addition, genotype may also influence an individual's response to a pharmacological intervention. In this study, we measured BDNF polymorphisms because they have been linked to neuroplasticity [<xref rid="B53" ref-type="bibr">53</xref>] and an increase in BDNF expression has been identified as a key mechanism in SSRI-induced recovery from amblyopia in mature rats [<xref rid="B44" ref-type="bibr">44</xref>]. There was no relationship between BDNF polymorphism and treatment response in this study with both val/val and val66met carriers improving by 1 logMAR line or more. However, the small sample size precludes any strong conclusions.</p>
              <p>In agreement with Huttunen et al. [<xref rid="B51" ref-type="bibr">51</xref>], we found no effect of SSRI treatment on VEP parameters. This is in contrast to other emerging potential approaches to amblyopia treatment in adulthood such as the noninvasive brain stimulation technique anodal transcranial direct current stimulation that increases VEP amplitude [<xref rid="B28" ref-type="bibr">28</xref>]. The lack of any VEP changes is consistent with the lack of a treatment effect on any of the other outcome measures used within this study. Retinal electrophysiology was also conducted to rule out any retinal changes if a positive treatment effect was observed. No retinal changes were observed, in agreement with the overall study results.</p>
              <p>In addition to the small sample size, a weakness of our study is that one participant (P6) did not meet the visual acuity inclusion criteria. We retained this participant in the study due to difficulties with recruitment. We note that excluding this participant from the sample does not change the pattern of results.</p>
              <p>In conclusion, we found no effect of 2 weeks of combined citalopram and patching on amblyopic eye visual acuity in adults with amblyopia. This result may have been due to our study being underpowered as a result of recruitment challenges. Three out of seven participants did exhibit an amblyopic eye visual acuity improvement of 0.1 logMAR or more with combined citalopram and patching suggesting that further studies in this area may be warranted.</p>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>This study was supported by grants to BT from the Marsden Fund of New Zealand and the Canadian Institutes of Health Research (CIHR 365136).</p>
            </ack>
            <sec sec-type="data-availability">
              <title>Data Availability</title>
              <p>All clinical data are provided within the manuscript tables. Anonymized electrophysiological data are available from the authors upon request.</p>
            </sec>
            <sec>
              <title>Conflicts of Interest</title>
              <p>The authors have no conflicts of interest to declare.</p>
            </sec>
            <ref-list>
              <ref id="B1">
                <label>1</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Holmes</surname>
                      <given-names>J. M.</given-names>
                    </name>
                    <name>
                      <surname>Clarke</surname>
                      <given-names>M. P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Amblyopia</article-title>
                  <source>
                    <italic toggle="yes">The Lancet</italic>
                  </source>
                  <year>2006</year>
                  <volume>367</volume>
                  <issue>9519</issue>
                  <fpage>1343</fpage>
                  <lpage>1351</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(06)68581-4</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-33646062248</pub-id>
                </element-citation>
              </ref>
              <ref id="B2">
                <label>2</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maurer</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Mc</surname>
                      <given-names>K. S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Classification and diversity of amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Visual Neuroscience</italic>
                  </source>
                  <year>2018</year>
                  <volume>35, article E012</volume>
                  <pub-id pub-id-type="doi">10.1017/S0952523817000190</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-85049234809</pub-id>
                </element-citation>
              </ref>
              <ref id="B3">
                <label>3</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hamm</surname>
                      <given-names>L. M.</given-names>
                    </name>
                    <name>
                      <surname>Black</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Dai</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Thompson</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Global processing in amblyopia: a review</article-title>
                  <source>
                    <italic toggle="yes">Frontiers in Psychology</italic>
                  </source>
                  <year>2014</year>
                  <volume>5</volume>
                  <fpage>p. 583</fpage>
                  <pub-id pub-id-type="doi">10.3389/fpsyg.2014.00583</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84904571791</pub-id>
                </element-citation>
              </ref>
              <ref id="B4">
                <label>4</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wong</surname>
                      <given-names>A. M.</given-names>
                    </name>
                  </person-group>
                  <article-title>New concepts concerning the neural mechanisms of amblyopia and their clinical implications</article-title>
                  <source>
                    <italic toggle="yes">Canadian Journal of Ophthalmology</italic>
                  </source>
                  <year>2012</year>
                  <volume>47</volume>
                  <issue>5</issue>
                  <fpage>399</fpage>
                  <lpage>409</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jcjo.2012.05.002</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84869239405</pub-id>
                  <?supplied-pmid 23036539?>
                  <pub-id pub-id-type="pmid">23036539</pub-id>
                </element-citation>
              </ref>
              <ref id="B5">
                <label>5</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Meier</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Giaschi</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Unilateral amblyopia affects two eyes: fellow eye deficits in amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Investigative Opthalmology &amp; Visual Science</italic>
                  </source>
                  <year>2017</year>
                  <volume>58</volume>
                  <issue>3</issue>
                  <fpage>1779</fpage>
                  <lpage>1800</lpage>
                  <pub-id pub-id-type="doi">10.1167/iovs.16-20964</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-85016303875</pub-id>
                </element-citation>
              </ref>
              <ref id="B6">
                <label>6</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Holmes</surname>
                      <given-names>J. M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Designing clinical trials for amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Vision Research</italic>
                  </source>
                  <year>2015</year>
                  <volume>114</volume>
                  <fpage>41</fpage>
                  <lpage>47</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.visres.2015.01.029</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84943207543</pub-id>
                  <pub-id pub-id-type="pmid">25752747</pub-id>
                </element-citation>
              </ref>
              <ref id="B7">
                <label>7</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stewart</surname>
                      <given-names>C. E.</given-names>
                    </name>
                    <name>
                      <surname>Moseley</surname>
                      <given-names>M. J.</given-names>
                    </name>
                    <name>
                      <surname>Stephens</surname>
                      <given-names>D. A.</given-names>
                    </name>
                    <name>
                      <surname>Fielder</surname>
                      <given-names>A. R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS)</article-title>
                  <source>
                    <italic toggle="yes">Investigative Opthalmology &amp; Visual Science</italic>
                  </source>
                  <year>2004</year>
                  <volume>45</volume>
                  <issue>9</issue>
                  <fpage>3048</fpage>
                  <lpage>3054</lpage>
                  <pub-id pub-id-type="doi">10.1167/iovs.04-0250</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-4344631105</pub-id>
                </element-citation>
              </ref>
              <ref id="B8">
                <label>8</label>
                <element-citation publication-type="journal">
                  <collab>Pediatric Eye Disease Investigator Group Writing</collab>
                  <article-title>A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children</article-title>
                  <source>
                    <italic toggle="yes">Ophthalmology</italic>
                  </source>
                  <year>2010</year>
                  <volume>117</volume>
                  <issue>5</issue>
                  <fpage>998</fpage>
                  <lpage>1004.e6</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ophtha.2009.10.014</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-77951623202</pub-id>
                  <pub-id pub-id-type="pmid">20163869</pub-id>
                </element-citation>
              </ref>
              <ref id="B9">
                <label>9</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Repka</surname>
                      <given-names>M. X.</given-names>
                    </name>
                    <name>
                      <surname>Holmes</surname>
                      <given-names>J. M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Lessons from the amblyopia treatment studies</article-title>
                  <source>
                    <italic toggle="yes">Ophthalmology</italic>
                  </source>
                  <year>2012</year>
                  <volume>119</volume>
                  <issue>4</issue>
                  <fpage>657</fpage>
                  <lpage>658</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ophtha.2011.12.003</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84859244420</pub-id>
                  <pub-id pub-id-type="pmid">22472249</pub-id>
                </element-citation>
              </ref>
              <ref id="B10">
                <label>10</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Scheiman</surname>
                      <given-names>M. M.</given-names>
                    </name>
                    <name>
                      <surname>Hertle</surname>
                      <given-names>R. W.</given-names>
                    </name>
                    <name>
                      <surname>Beck</surname>
                      <given-names>R. W.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Randomized trial of treatment of amblyopia in children aged 7 to 17 years</article-title>
                  <source>
                    <italic toggle="yes">Archives of Ophthalmology</italic>
                  </source>
                  <year>2005</year>
                  <volume>123</volume>
                  <issue>4</issue>
                  <fpage>437</fpage>
                  <lpage>447</lpage>
                  <pub-id pub-id-type="doi">10.1001/archopht.123.4.437</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-16844380718</pub-id>
                  <?supplied-pmid 15824215?>
                  <pub-id pub-id-type="pmid">15824215</pub-id>
                </element-citation>
              </ref>
              <ref id="B11">
                <label>11</label>
                <element-citation publication-type="journal">
                  <collab>Pediatric Eye Disease Investigator Group</collab>
                  <article-title>Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial</article-title>
                  <source>
                    <italic toggle="yes">Archives of Ophthalmology</italic>
                  </source>
                  <year>2008</year>
                  <volume>126</volume>
                  <issue>12</issue>
                  <fpage>1634</fpage>
                  <lpage>1642</lpage>
                  <pub-id pub-id-type="doi">10.1001/archophthalmol.2008.107</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-58149243043</pub-id>
                  <?supplied-pmid 19064841?>
                  <pub-id pub-id-type="pmid">19064841</pub-id>
                </element-citation>
              </ref>
              <ref id="B12">
                <label>12</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wallace</surname>
                      <given-names>D. K.</given-names>
                    </name>
                    <name>
                      <surname>Pediatric Eye Disease Investigator Group</surname>
                    </name>
                  </person-group>
                  <article-title>A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children</article-title>
                  <source>
                    <italic toggle="yes">Ophthalmology</italic>
                  </source>
                  <year>2006</year>
                  <volume>113</volume>
                  <issue>6</issue>
                  <fpage>904</fpage>
                  <lpage>912</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ophtha.2006.01.069</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-33646904494</pub-id>
                  <?supplied-pmid 16751033?>
                  <pub-id pub-id-type="pmid">16751033</pub-id>
                </element-citation>
              </ref>
              <ref id="B13">
                <label>13</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stewart</surname>
                      <given-names>C. E.</given-names>
                    </name>
                    <name>
                      <surname>Stephens</surname>
                      <given-names>D. A.</given-names>
                    </name>
                    <name>
                      <surname>Fielder</surname>
                      <given-names>A. R.</given-names>
                    </name>
                    <name>
                      <surname>Moseley</surname>
                      <given-names>M. J.</given-names>
                    </name>
                    <name>
                      <surname>Cooperative</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Modeling dose-response in amblyopia: toward a child-specific treatment plan</article-title>
                  <source>
                    <italic toggle="yes">Investigative Opthalmology &amp; Visual Science</italic>
                  </source>
                  <year>2007</year>
                  <volume>48</volume>
                  <issue>6</issue>
                  <fpage>2589</fpage>
                  <lpage>2594</lpage>
                  <pub-id pub-id-type="doi">10.1167/iovs.05-1243</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-34347257819</pub-id>
                </element-citation>
              </ref>
              <ref id="B14">
                <label>14</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Holmes</surname>
                      <given-names>J. M.</given-names>
                    </name>
                    <name>
                      <surname>Levi</surname>
                      <given-names>D. M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Treatment of amblyopia as a function of age</article-title>
                  <source>
                    <italic toggle="yes">Visual Neuroscience</italic>
                  </source>
                  <year>2018</year>
                  <volume>35, article E015</volume>
                  <pub-id pub-id-type="doi">10.1017/S0952523817000220</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-85041669013</pub-id>
                </element-citation>
              </ref>
              <ref id="B15">
                <label>15</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Holmes</surname>
                      <given-names>J. M.</given-names>
                    </name>
                    <name>
                      <surname>Lazar</surname>
                      <given-names>E. L.</given-names>
                    </name>
                    <name>
                      <surname>Melia</surname>
                      <given-names>B. M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effect of age on response to amblyopia treatment in children</article-title>
                  <source>
                    <italic toggle="yes">Archives of Ophthalmology</italic>
                  </source>
                  <year>2011</year>
                  <volume>129</volume>
                  <issue>11</issue>
                  <fpage>1451</fpage>
                  <lpage>1457</lpage>
                  <pub-id pub-id-type="doi">10.1001/archophthalmol.2011.179</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-81355164224</pub-id>
                  <?supplied-pmid 21746970?>
                  <pub-id pub-id-type="pmid">21746970</pub-id>
                </element-citation>
              </ref>
              <ref id="B16">
                <label>16</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fronius</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Cirina</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Ackermann</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Kohnen</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Diehl</surname>
                      <given-names>C. M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficiency of electronically monitored amblyopia treatment between 5 and 16 years of age: new insight into declining susceptibility of the visual system</article-title>
                  <source>
                    <italic toggle="yes">Vision Research</italic>
                  </source>
                  <year>2014</year>
                  <volume>103</volume>
                  <fpage>11</fpage>
                  <lpage>19</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.visres.2014.07.018</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84908133950</pub-id>
                  <?supplied-pmid 25130409?>
                  <pub-id pub-id-type="pmid">25130409</pub-id>
                </element-citation>
              </ref>
              <ref id="B17">
                <label>17</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Blakemore</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Van Sluyters</surname>
                      <given-names>R. C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Reversal of the physiological effects of monocular deprivation in kittens: further evidence for a sensitive period</article-title>
                  <source>
                    <italic toggle="yes">The Journal of Physiology</italic>
                  </source>
                  <year>1974</year>
                  <volume>237</volume>
                  <issue>1</issue>
                  <fpage>195</fpage>
                  <lpage>216</lpage>
                  <pub-id pub-id-type="doi">10.1113/jphysiol.1974.sp010478</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-0015981702</pub-id>
                  <?supplied-pmid 4595664?>
                  <pub-id pub-id-type="pmid">4595664</pub-id>
                </element-citation>
              </ref>
              <ref id="B18">
                <label>18</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hubel</surname>
                      <given-names>D. H.</given-names>
                    </name>
                    <name>
                      <surname>Wiesel</surname>
                      <given-names>T. N.</given-names>
                    </name>
                  </person-group>
                  <article-title>The period of susceptibility to the physiological effects of unilateral eye closure in kittens</article-title>
                  <source>
                    <italic toggle="yes">The Journal of Physiology</italic>
                  </source>
                  <year>1970</year>
                  <volume>206</volume>
                  <issue>2</issue>
                  <fpage>419</fpage>
                  <lpage>436</lpage>
                  <pub-id pub-id-type="doi">10.1113/jphysiol.1970.sp009022</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-0014737492</pub-id>
                  <?supplied-pmid 5498493?>
                  <pub-id pub-id-type="pmid">5498493</pub-id>
                </element-citation>
              </ref>
              <ref id="B19">
                <label>19</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Movshon</surname>
                      <given-names>J. A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Reversal of the physiological effects of monocular deprivation in the kitten’s visual cortex</article-title>
                  <source>
                    <italic toggle="yes">The Journal of Physiology</italic>
                  </source>
                  <year>1976</year>
                  <volume>261</volume>
                  <issue>1</issue>
                  <fpage>125</fpage>
                  <lpage>174</lpage>
                  <pub-id pub-id-type="doi">10.1113/jphysiol.1976.sp011551</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-0017144820</pub-id>
                  <?supplied-pmid 994027?>
                  <pub-id pub-id-type="pmid">994027</pub-id>
                </element-citation>
              </ref>
              <ref id="B20">
                <label>20</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Daw</surname>
                      <given-names>N. W.</given-names>
                    </name>
                  </person-group>
                  <source>
                    <italic toggle="yes">Visual development</italic>
                  </source>
                  <year>2014</year>
                  <edition>3rd edition</edition>
                  <publisher-loc>New York, NY, USA</publisher-loc>
                  <publisher-name>Springer</publisher-name>
                  <pub-id pub-id-type="doi">10.1007/978-1-4614-9059-3</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84929862761</pub-id>
                </element-citation>
              </ref>
              <ref id="B21">
                <label>21</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Levi</surname>
                      <given-names>D. M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Perceptual learning in adults with amblyopia: a reevaluation of critical periods in human vision</article-title>
                  <source>
                    <italic toggle="yes">Developmental Psychobiology</italic>
                  </source>
                  <year>2005</year>
                  <volume>46</volume>
                  <issue>3</issue>
                  <fpage>222</fpage>
                  <lpage>232</lpage>
                  <pub-id pub-id-type="doi">10.1002/dev.20050</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-17844368892</pub-id>
                  <pub-id pub-id-type="pmid">15772964</pub-id>
                </element-citation>
              </ref>
              <ref id="B22">
                <label>22</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Levi</surname>
                      <given-names>D. M.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>R. W.</given-names>
                    </name>
                  </person-group>
                  <article-title>Perceptual learning as a potential treatment for amblyopia: a mini-review</article-title>
                  <source>
                    <italic toggle="yes">Vision Research</italic>
                  </source>
                  <year>2009</year>
                  <volume>49</volume>
                  <issue>21</issue>
                  <fpage>2535</fpage>
                  <lpage>2549</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.visres.2009.02.010</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-70349923427</pub-id>
                  <?supplied-pmid 19250947?>
                  <pub-id pub-id-type="pmid">19250947</pub-id>
                </element-citation>
              </ref>
              <ref id="B23">
                <label>23</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hess</surname>
                      <given-names>R. F.</given-names>
                    </name>
                    <name>
                      <surname>Thompson</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Amblyopia and the binocular approach to its therapy</article-title>
                  <source>
                    <italic toggle="yes">Vision Research</italic>
                  </source>
                  <year>2015</year>
                  <volume>114</volume>
                  <fpage>4</fpage>
                  <lpage>16</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.visres.2015.02.009</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84943457701</pub-id>
                  <?supplied-pmid 25906685?>
                  <pub-id pub-id-type="pmid">25906685</pub-id>
                </element-citation>
              </ref>
              <ref id="B24">
                <label>24</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hess</surname>
                      <given-names>R. F.</given-names>
                    </name>
                    <name>
                      <surname>Thompson</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>D. H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Binocular vision in amblyopia: structure, suppression and plasticity</article-title>
                  <source>
                    <italic toggle="yes">Ophthalmic and Physiological Optics</italic>
                  </source>
                  <year>2014</year>
                  <volume>34</volume>
                  <issue>2</issue>
                  <fpage>146</fpage>
                  <lpage>162</lpage>
                  <pub-id pub-id-type="doi">10.1111/opo.12123</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84894262369</pub-id>
                  <?supplied-pmid 24588532?>
                  <pub-id pub-id-type="pmid">24588532</pub-id>
                </element-citation>
              </ref>
              <ref id="B25">
                <label>25</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Spiegel</surname>
                      <given-names>D. P.</given-names>
                    </name>
                    <name>
                      <surname>Hess</surname>
                      <given-names>R. F.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Dichoptic training improves contrast sensitivity in adults with amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Vision Research</italic>
                  </source>
                  <year>2015</year>
                  <volume>114</volume>
                  <fpage>161</fpage>
                  <lpage>172</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.visres.2015.01.017</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84943207592</pub-id>
                  <?supplied-pmid 25676883?>
                  <pub-id pub-id-type="pmid">25676883</pub-id>
                </element-citation>
              </ref>
              <ref id="B26">
                <label>26</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Thompson</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Deng</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Chan</surname>
                      <given-names>L. Y.</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hess</surname>
                      <given-names>R. F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Dichoptic training enables the adult amblyopic brain to learn</article-title>
                  <source>
                    <italic toggle="yes">Current Biology</italic>
                  </source>
                  <year>2013</year>
                  <volume>23</volume>
                  <issue>8</issue>
                  <fpage>R308</fpage>
                  <lpage>R309</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cub.2013.01.059</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84876772723</pub-id>
                  <?supplied-pmid 23618662?>
                  <pub-id pub-id-type="pmid">23618662</pub-id>
                </element-citation>
              </ref>
              <ref id="B27">
                <label>27</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vedamurthy</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Nahum</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>S. J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A dichoptic custom-made action video game as a treatment for adult amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Vision Research</italic>
                  </source>
                  <year>2015</year>
                  <volume>114</volume>
                  <fpage>173</fpage>
                  <lpage>187</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.visres.2015.04.008</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84943207561</pub-id>
                  <?supplied-pmid 25917239?>
                  <pub-id pub-id-type="pmid">25917239</pub-id>
                </element-citation>
              </ref>
              <ref id="B28">
                <label>28</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ding</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Spiegel</surname>
                      <given-names>D. P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The effect of transcranial direct current stimulation on contrast sensitivity and visual evoked potential amplitude in adults with amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Scientific Reports</italic>
                  </source>
                  <year>2016</year>
                  <volume>6</volume>
                  <issue>1, article 19280</issue>
                  <pub-id pub-id-type="doi">10.1038/srep19280</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84955126982</pub-id>
                </element-citation>
              </ref>
              <ref id="B29">
                <label>29</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moret</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Camilleri</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Pavan</surname>
                      <given-names>A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Differential effects of high-frequency transcranial random noise stimulation (hf-tRNS) on contrast sensitivity and visual acuity when combined with a short perceptual training in adults with amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Neuropsychologia</italic>
                  </source>
                  <year>2018</year>
                  <volume>114</volume>
                  <fpage>125</fpage>
                  <lpage>133</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuropsychologia.2018.04.017</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-85046378060</pub-id>
                  <?supplied-pmid 29704524?>
                  <pub-id pub-id-type="pmid">29704524</pub-id>
                </element-citation>
              </ref>
              <ref id="B30">
                <label>30</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spiegel</surname>
                      <given-names>D. P.</given-names>
                    </name>
                    <name>
                      <surname>Byblow</surname>
                      <given-names>W. D.</given-names>
                    </name>
                    <name>
                      <surname>Hess</surname>
                      <given-names>R. F.</given-names>
                    </name>
                    <name>
                      <surname>Thompson</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Anodal transcranial direct current stimulation transiently improves contrast sensitivity and normalizes visual cortex activation in individuals with amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Neurorehabil Neural Repair</italic>
                  </source>
                  <year>2013</year>
                  <volume>27</volume>
                  <issue>8</issue>
                  <fpage>760</fpage>
                  <lpage>769</lpage>
                  <pub-id pub-id-type="doi">10.1177/1545968313491006</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84884579603</pub-id>
                  <?supplied-pmid 23774122?>
                  <pub-id pub-id-type="pmid">23774122</pub-id>
                </element-citation>
              </ref>
              <ref id="B31">
                <label>31</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spiegel</surname>
                      <given-names>D. P.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hess</surname>
                      <given-names>R. F.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Transcranial direct current stimulation enhances recovery of stereopsis in adults with amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Neurotherapeutics</italic>
                  </source>
                  <year>2013</year>
                  <volume>10</volume>
                  <issue>4</issue>
                  <fpage>831</fpage>
                  <lpage>839</lpage>
                  <pub-id pub-id-type="doi">10.1007/s13311-013-0200-y</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84886292984</pub-id>
                  <pub-id pub-id-type="pmid">23857313</pub-id>
                </element-citation>
              </ref>
              <ref id="B32">
                <label>32</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thompson</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Mansouri</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Koski</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Hess</surname>
                      <given-names>R. F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Brain plasticity in the adult: modulation of function in amblyopia with rTMS</article-title>
                  <source>
                    <italic toggle="yes">Current Biology</italic>
                  </source>
                  <year>2008</year>
                  <volume>18</volume>
                  <issue>14</issue>
                  <fpage>1067</fpage>
                  <lpage>1071</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cub.2008.06.052</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-47049122950</pub-id>
                  <?supplied-pmid 18635353?>
                  <pub-id pub-id-type="pmid">18635353</pub-id>
                </element-citation>
              </ref>
              <ref id="B33">
                <label>33</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gao</surname>
                      <given-names>T. Y.</given-names>
                    </name>
                    <name>
                      <surname>Guo</surname>
                      <given-names>C. X.</given-names>
                    </name>
                    <name>
                      <surname>Babu</surname>
                      <given-names>R. J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effectiveness of a binocular video game vs placebo video game for improving visual functions in older children, teenagers, and adults with amblyopia: a randomized clinical trial</article-title>
                  <source>
                    <italic toggle="yes">JAMA Ophthalmology</italic>
                  </source>
                  <year>2018</year>
                  <volume>136</volume>
                  <issue>2</issue>
                  <fpage>172</fpage>
                  <lpage>181</lpage>
                  <pub-id pub-id-type="doi">10.1001/jamaophthalmol.2017.6090</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-85041653816</pub-id>
                  <?supplied-pmid 29302694?>
                  <pub-id pub-id-type="pmid">29302694</pub-id>
                </element-citation>
              </ref>
              <ref id="B34">
                <label>34</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Morishita</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Hensch</surname>
                      <given-names>T. K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Critical period revisited: impact on vision</article-title>
                  <source>
                    <italic toggle="yes">Current Opinion in Neurobiology</italic>
                  </source>
                  <year>2008</year>
                  <volume>18</volume>
                  <issue>1</issue>
                  <fpage>101</fpage>
                  <lpage>107</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.conb.2008.05.009</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-46549086820</pub-id>
                  <?supplied-pmid 18534841?>
                  <pub-id pub-id-type="pmid">18534841</pub-id>
                </element-citation>
              </ref>
              <ref id="B35">
                <label>35</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mitchell</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Sengpiel</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Animal models of amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Visual Neuroscience</italic>
                  </source>
                  <year>2018</year>
                  <volume>35, article E017</volume>
                  <pub-id pub-id-type="doi">10.1017/S0952523817000244</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-85049250468</pub-id>
                </element-citation>
              </ref>
              <ref id="B36">
                <label>36</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stryker</surname>
                      <given-names>M. P.</given-names>
                    </name>
                    <name>
                      <surname>Löwel</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Amblyopia: new molecular/pharmacological and environmental approaches</article-title>
                  <source>
                    <italic toggle="yes">Visual Neuroscience</italic>
                  </source>
                  <year>2018</year>
                  <volume>35, article E018</volume>
                  <pub-id pub-id-type="doi">10.1017/S0952523817000256</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-85049264655</pub-id>
                </element-citation>
              </ref>
              <ref id="B37">
                <label>37</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>He</surname>
                      <given-names>H. Y.</given-names>
                    </name>
                    <name>
                      <surname>Ray</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Dennis</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Quinlan</surname>
                      <given-names>E. M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Experience-dependent recovery of vision following chronic deprivation amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Nature Neuroscience</italic>
                  </source>
                  <year>2007</year>
                  <volume>10</volume>
                  <issue>9</issue>
                  <fpage>1134</fpage>
                  <lpage>1136</lpage>
                  <pub-id pub-id-type="doi">10.1038/nn1965</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-34548321217</pub-id>
                  <?supplied-pmid 17694050?>
                  <pub-id pub-id-type="pmid">17694050</pub-id>
                </element-citation>
              </ref>
              <ref id="B38">
                <label>38</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Duffy</surname>
                      <given-names>K. R.</given-names>
                    </name>
                    <name>
                      <surname>Mitchell</surname>
                      <given-names>D. E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Darkness alters maturation of visual cortex and promotes fast recovery from monocular deprivation</article-title>
                  <source>
                    <italic toggle="yes">Current Biology</italic>
                  </source>
                  <year>2013</year>
                  <volume>23</volume>
                  <issue>5</issue>
                  <fpage>382</fpage>
                  <lpage>386</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cub.2013.01.017</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84875226646</pub-id>
                  <?supplied-pmid 23416100?>
                  <pub-id pub-id-type="pmid">23416100</pub-id>
                </element-citation>
              </ref>
              <ref id="B39">
                <label>39</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sale</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Maya Vetencourt</surname>
                      <given-names>J. F.</given-names>
                    </name>
                    <name>
                      <surname>Medini</surname>
                      <given-names>P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Environmental enrichment in adulthood promotes amblyopia recovery through a reduction of intracortical inhibition</article-title>
                  <source>
                    <italic toggle="yes">Nature Neuroscience</italic>
                  </source>
                  <year>2007</year>
                  <volume>10</volume>
                  <issue>6</issue>
                  <fpage>679</fpage>
                  <lpage>681</lpage>
                  <pub-id pub-id-type="doi">10.1038/nn1899</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-34249667112</pub-id>
                  <?supplied-pmid 17468749?>
                  <pub-id pub-id-type="pmid">17468749</pub-id>
                </element-citation>
              </ref>
              <ref id="B40">
                <label>40</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Spolidoro</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Baroncelli</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Putignano</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Maya-Vetencourt</surname>
                      <given-names>J. F.</given-names>
                    </name>
                    <name>
                      <surname>Viegi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Maffei</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Food restriction enhances visual cortex plasticity in adulthood</article-title>
                  <source>
                    <italic toggle="yes">Nature Communications</italic>
                  </source>
                  <year>2011</year>
                  <volume>2</volume>
                  <issue>1</issue>
                  <fpage>p. 320</fpage>
                  <pub-id pub-id-type="doi">10.1038/ncomms1323</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-79956283069</pub-id>
                </element-citation>
              </ref>
              <ref id="B41">
                <label>41</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Murphy</surname>
                      <given-names>K. M.</given-names>
                    </name>
                    <name>
                      <surname>Roumeliotis</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Beston</surname>
                      <given-names>B. R.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>D. G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Binocular visual training to promote recovery from monocular deprivation</article-title>
                  <source>
                    <italic toggle="yes">Journal of Vision</italic>
                  </source>
                  <year>2015</year>
                  <volume>15</volume>
                  <issue>1</issue>
                  <fpage>p. 2</fpage>
                  <pub-id pub-id-type="doi">10.1167/15.1.2</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84921636814</pub-id>
                  <?supplied-pmid 25572348?>
                  <pub-id pub-id-type="pmid">26562310</pub-id>
                </element-citation>
              </ref>
              <ref id="B42">
                <label>42</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaneko</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Stryker</surname>
                      <given-names>M. P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Sensory experience during locomotion promotes recovery of function in adult visual cortex</article-title>
                  <source>
                    <italic toggle="yes">Elife</italic>
                  </source>
                  <year>2014</year>
                  <volume>3, article e02798</volume>
                  <pub-id pub-id-type="doi">10.7554/eLife.02798</pub-id>
                </element-citation>
              </ref>
              <ref id="B43">
                <label>43</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fong</surname>
                      <given-names>M. F.</given-names>
                    </name>
                    <name>
                      <surname>Mitchell</surname>
                      <given-names>D. E.</given-names>
                    </name>
                    <name>
                      <surname>Duffy</surname>
                      <given-names>K. R.</given-names>
                    </name>
                    <name>
                      <surname>Bear</surname>
                      <given-names>M. F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Rapid recovery from the effects of early monocular deprivation is enabled by temporary inactivation of the retinas</article-title>
                  <source>
                    <italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
                  </source>
                  <year>2016</year>
                  <volume>113</volume>
                  <issue>49</issue>
                  <fpage>14139</fpage>
                  <lpage>14144</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1613279113</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-85002735827</pub-id>
                  <?supplied-pmid 27856748?>
                  <pub-id pub-id-type="pmid">27856748</pub-id>
                </element-citation>
              </ref>
              <ref id="B44">
                <label>44</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maya Vetencourt</surname>
                      <given-names>J. F.</given-names>
                    </name>
                    <name>
                      <surname>Sale</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Viegi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The antidepressant fluoxetine restores plasticity in the adult visual cortex</article-title>
                  <source>
                    <italic toggle="yes">Science</italic>
                  </source>
                  <year>2008</year>
                  <volume>320</volume>
                  <issue>5874</issue>
                  <fpage>385</fpage>
                  <lpage>388</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.1150516</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-42349094651</pub-id>
                  <pub-id pub-id-type="pmid">18420937</pub-id>
                </element-citation>
              </ref>
              <ref id="B45">
                <label>45</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Loubinoux</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Pariente</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Rascol</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Celsis</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Chollet</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Selective serotonin reuptake inhibitor paroxetine modulates motor behavior through practice. A double-blind, placebo-controlled, multi-dose study in healthy subjects</article-title>
                  <source>
                    <italic toggle="yes">Neuropsychologia</italic>
                  </source>
                  <year>2002</year>
                  <volume>40</volume>
                  <issue>11</issue>
                  <fpage>1815</fpage>
                  <lpage>1821</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0028-3932(02)00030-1</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-0036286736</pub-id>
                  <?supplied-pmid 12062893?>
                  <pub-id pub-id-type="pmid">12062893</pub-id>
                </element-citation>
              </ref>
              <ref id="B46">
                <label>46</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Loubinoux</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Tombari</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Pariente</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer</article-title>
                  <source>
                    <italic toggle="yes">Neuroimage</italic>
                  </source>
                  <year>2005</year>
                  <volume>27</volume>
                  <issue>2</issue>
                  <fpage>299</fpage>
                  <lpage>313</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.neuroimage.2004.12.023</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-23044502894</pub-id>
                  <pub-id pub-id-type="pmid">15950492</pub-id>
                </element-citation>
              </ref>
              <ref id="B47">
                <label>47</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Normann</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Schmitz</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Furmaier</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Doing</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bach</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Long-term plasticity of visually evoked potentials in humans is altered in major depression</article-title>
                  <source>
                    <italic toggle="yes">Biological Psychiatry</italic>
                  </source>
                  <year>2007</year>
                  <volume>62</volume>
                  <issue>5</issue>
                  <fpage>373</fpage>
                  <lpage>380</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.10.006</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-34548034021</pub-id>
                  <pub-id pub-id-type="pmid">17240361</pub-id>
                </element-citation>
              </ref>
              <ref id="B48">
                <label>48</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chollet</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Tardy</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Albucher</surname>
                      <given-names>J. F.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial</article-title>
                  <source>
                    <italic toggle="yes">The Lancet Neurology</italic>
                  </source>
                  <year>2011</year>
                  <volume>10</volume>
                  <issue>2</issue>
                  <fpage>123</fpage>
                  <lpage>130</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70314-8</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-78751580257</pub-id>
                  <pub-id pub-id-type="pmid">21216670</pub-id>
                </element-citation>
              </ref>
              <ref id="B49">
                <label>49</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lagas</surname>
                      <given-names>A. K.</given-names>
                    </name>
                    <name>
                      <surname>Black</surname>
                      <given-names>J. M.</given-names>
                    </name>
                    <name>
                      <surname>Byblow</surname>
                      <given-names>W. D.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Fluoxetine does not enhance visual perceptual learning and triazolam specifically impairs learning transfer</article-title>
                  <source>
                    <italic toggle="yes">Frontiers in Human Neuroscience</italic>
                  </source>
                  <year>2016</year>
                  <volume>10</volume>
                  <pub-id pub-id-type="doi">10.3389/fnhum.2016.00532</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84992493704</pub-id>
                </element-citation>
              </ref>
              <ref id="B50">
                <label>50</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sharif</surname>
                      <given-names>M. H.</given-names>
                    </name>
                    <name>
                      <surname>Talebnejad</surname>
                      <given-names>M. R.</given-names>
                    </name>
                    <name>
                      <surname>Rastegar</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Khalili</surname>
                      <given-names>M. R.</given-names>
                    </name>
                    <name>
                      <surname>Nowroozzadeh</surname>
                      <given-names>M. H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial</article-title>
                  <source>
                    <italic toggle="yes">Eye</italic>
                  </source>
                  <year>2019</year>
                  <pub-id pub-id-type="doi">10.1038/s41433-019-0360-z</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-85061908858</pub-id>
                </element-citation>
              </ref>
              <ref id="B51">
                <label>51</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huttunen</surname>
                      <given-names>H. J.</given-names>
                    </name>
                    <name>
                      <surname>Palva</surname>
                      <given-names>J. M.</given-names>
                    </name>
                    <name>
                      <surname>Lindberg</surname>
                      <given-names>L.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Scientific Reports</italic>
                  </source>
                  <year>2018</year>
                  <volume>8</volume>
                  <issue>1, article 12830</issue>
                  <pub-id pub-id-type="doi">10.1038/s41598-018-31169-z</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-85052289221</pub-id>
                  <?supplied-pmid 30150750?>
                  <pub-id pub-id-type="pmid">30150750</pub-id>
                </element-citation>
              </ref>
              <ref id="B52">
                <label>52</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baumann</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Pharmacology and pharmacokinetics of citalopram and other SSRIs</article-title>
                  <source>
                    <italic toggle="yes">International Clinical Psychopharmacology</italic>
                  </source>
                  <year>1996</year>
                  <volume>11</volume>
                  <fpage>5</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="doi">10.1097/00004850-199603001-00002</pub-id>
                  <pub-id pub-id-type="pmid">8732438</pub-id>
                </element-citation>
              </ref>
              <ref id="B53">
                <label>53</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kleim</surname>
                      <given-names>J. A.</given-names>
                    </name>
                    <name>
                      <surname>Chan</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Pringle</surname>
                      <given-names>E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex</article-title>
                  <source>
                    <italic toggle="yes">Nature Neuroscience</italic>
                  </source>
                  <year>2006</year>
                  <volume>9</volume>
                  <issue>6</issue>
                  <fpage>735</fpage>
                  <lpage>737</lpage>
                  <pub-id pub-id-type="doi">10.1038/nn1699</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-33745684614</pub-id>
                  <?supplied-pmid 16680163?>
                  <pub-id pub-id-type="pmid">16680163</pub-id>
                </element-citation>
              </ref>
              <ref id="B54">
                <label>54</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chung</surname>
                      <given-names>S. T. L.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>R. W.</given-names>
                    </name>
                    <name>
                      <surname>Silver</surname>
                      <given-names>M. A.</given-names>
                    </name>
                    <name>
                      <surname>Levi</surname>
                      <given-names>D. M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Donepezil does not enhance perceptual learning in adults with amblyopia: a pilot study</article-title>
                  <source>
                    <italic toggle="yes">Frontiers in Neuroscience</italic>
                  </source>
                  <year>2017</year>
                  <volume>11</volume>
                  <fpage>p. 448</fpage>
                  <pub-id pub-id-type="doi">10.3389/fnins.2017.00448</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-85027153644</pub-id>
                </element-citation>
              </ref>
              <ref id="B55">
                <label>55</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pediatric Eye Disease Investigator Group</surname>
                    </name>
                    <name>
                      <surname>Repka</surname>
                      <given-names>M. X.</given-names>
                    </name>
                    <name>
                      <surname>Kraker</surname>
                      <given-names>R. T.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A randomized trial of levodopa as treatment for residual amblyopia in older children</article-title>
                  <source>
                    <italic toggle="yes">Ophthalmology</italic>
                  </source>
                  <year>2015</year>
                  <volume>122</volume>
                  <issue>5</issue>
                  <fpage>874</fpage>
                  <lpage>881</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ophtha.2015.01.002</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-84928803228</pub-id>
                  <?supplied-pmid 25676904?>
                  <pub-id pub-id-type="pmid">25676904</pub-id>
                </element-citation>
              </ref>
              <ref id="B56">
                <label>56</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Epelbaum</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Milleret</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Buisseret</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Dufier</surname>
                      <given-names>J. L.</given-names>
                    </name>
                  </person-group>
                  <article-title>The sensitive period for strabismic amblyopia in humans</article-title>
                  <source>
                    <italic toggle="yes">Ophthalmology</italic>
                  </source>
                  <year>1993</year>
                  <volume>100</volume>
                  <issue>3</issue>
                  <fpage>323</fpage>
                  <lpage>327</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0161-6420(13)32170-8</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-0027413108</pub-id>
                  <?supplied-pmid 8460000?>
                  <pub-id pub-id-type="pmid">8460000</pub-id>
                </element-citation>
              </ref>
              <ref id="B57">
                <label>57</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Levi</surname>
                      <given-names>D. M.</given-names>
                    </name>
                    <name>
                      <surname>Polat</surname>
                      <given-names>U.</given-names>
                    </name>
                  </person-group>
                  <article-title>Neural plasticity in adults with amblyopia</article-title>
                  <source>
                    <italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
                  </source>
                  <year>1996</year>
                  <volume>93</volume>
                  <issue>13</issue>
                  <fpage>6830</fpage>
                  <lpage>6834</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.93.13.6830</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-0029999448</pub-id>
                  <?supplied-pmid 8692904?>
                  <pub-id pub-id-type="pmid">8692904</pub-id>
                </element-citation>
              </ref>
              <ref id="B58">
                <label>58</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bezchlibnyk-Butler</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Aleksic</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Kennedy</surname>
                      <given-names>S. H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Citalopram--a review of pharmacological and clinical effects</article-title>
                  <source>
                    <italic toggle="yes">Journal of Psychiatry and Neuroscience</italic>
                  </source>
                  <year>2000</year>
                  <volume>25</volume>
                  <issue>3</issue>
                  <fpage>241</fpage>
                  <lpage>254</lpage>
                  <?supplied-pmid 10863884?>
                  <pub-id pub-id-type="pmid">10863884</pub-id>
                </element-citation>
              </ref>
              <ref id="B59">
                <label>59</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gury</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Cousin</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability</article-title>
                  <source>
                    <italic toggle="yes">Encephale</italic>
                  </source>
                  <year>1999</year>
                  <volume>25</volume>
                  <issue>5</issue>
                  <fpage>470</fpage>
                  <lpage>476</lpage>
                  <?supplied-pmid 10598311?>
                  <pub-id pub-id-type="pmid">10598311</pub-id>
                </element-citation>
              </ref>
              <ref id="B60">
                <label>60</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Patris</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bouchard</surname>
                      <given-names>J. M.</given-names>
                    </name>
                    <name>
                      <surname>Bougerol</surname>
                      <given-names>T.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice</article-title>
                  <source>
                    <italic toggle="yes">International Clinical Psychopharmacology</italic>
                  </source>
                  <year>1996</year>
                  <volume>11</volume>
                  <issue>2</issue>
                  <fpage>129</fpage>
                  <lpage>136</lpage>
                  <pub-id pub-id-type="doi">10.1097/00004850-199606000-00007</pub-id>
                  <?supplied-pmid 8803650?>
                  <pub-id pub-id-type="pmid">8803650</pub-id>
                </element-citation>
              </ref>
              <ref id="B61">
                <label>61</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kucukibrahimoglu</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Saygin</surname>
                      <given-names>M. Z.</given-names>
                    </name>
                    <name>
                      <surname>Caliskan</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kaplan</surname>
                      <given-names>O. K.</given-names>
                    </name>
                    <name>
                      <surname>Unsal</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Goren</surname>
                      <given-names>M. Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression</article-title>
                  <source>
                    <italic toggle="yes">European Journal of Clinical Pharmacology</italic>
                  </source>
                  <year>2009</year>
                  <volume>65</volume>
                  <issue>6</issue>
                  <fpage>571</fpage>
                  <lpage>577</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00228-009-0650-7</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-68849108132</pub-id>
                  <?supplied-pmid 19373461?>
                  <pub-id pub-id-type="pmid">19373461</pub-id>
                </element-citation>
              </ref>
              <ref id="B62">
                <label>62</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Owens</surname>
                      <given-names>M. J.</given-names>
                    </name>
                    <name>
                      <surname>Knight</surname>
                      <given-names>D. L.</given-names>
                    </name>
                    <name>
                      <surname>Nemeroff</surname>
                      <given-names>C. B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine</article-title>
                  <source>
                    <italic toggle="yes">Biological Psychiatry</italic>
                  </source>
                  <year>2001</year>
                  <volume>50</volume>
                  <issue>5</issue>
                  <fpage>345</fpage>
                  <lpage>350</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0006-3223(01)01145-3</pub-id>
                  <pub-id pub-id-type="other">2-s2.0-0035450364</pub-id>
                  <?supplied-pmid 11543737?>
                  <pub-id pub-id-type="pmid">11543737</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="fig1" orientation="portrait" position="float">
              <label>Figure 1</label>
              <caption>
                <p>Schematic of the study protocol and the timing of baseline, outcome, and follow-up measures.</p>
              </caption>
              <graphic xlink:href="NP2019-5857243.001"/>
            </fig>
            <fig id="fig2" orientation="portrait" position="float">
              <label>Figure 2</label>
              <caption>
                <p>CONSORT diagram for the study.</p>
              </caption>
              <graphic xlink:href="NP2019-5857243.002"/>
            </fig>
            <fig id="fig3" orientation="portrait" position="float">
              <label>Figure 3</label>
              <caption>
                <p>VEP results for the 1° check stimulus. Latencies for the P100 component are shown in (a), and amplitudes for the N57-P100 waveform component are in (b). Individual participants are shown with different symbols—P1-7 as follows: filled circle, filled square, filled triangle, filled diamond, filled hexagon, open circle, and open square, respectively. Horizontal lines depict group mean values.</p>
              </caption>
              <graphic xlink:href="NP2019-5857243.003"/>
            </fig>
            <fig id="fig4" orientation="portrait" position="float">
              <label>Figure 4</label>
              <caption>
                <p>Multifocal ERG results for participant P7 (first baseline session).</p>
              </caption>
              <graphic xlink:href="NP2019-5857243.004"/>
            </fig>
            <fig id="fig5" orientation="portrait" position="float">
              <label>Figure 5</label>
              <caption>
                <p>Pattern ERG (a, b) and pattern reversal VEP (c, d) results for the amblyopic (a, c) and fellow (b, d) eyes of participant P7 (first baseline session).</p>
              </caption>
              <graphic xlink:href="NP2019-5857243.005"/>
            </fig>
            <table-wrap id="tab1" content-type="sidewaystable" orientation="portrait" position="float">
              <label>Table 1</label>
              <caption>
                <p>Participant details.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th rowspan="1" colspan="1"/>
                    <th align="center" rowspan="1" colspan="1">Age/sex</th>
                    <th align="center" rowspan="1" colspan="1">AME VA logMAR</th>
                    <th align="center" rowspan="1" colspan="1">FFE VA logMAR</th>
                    <th align="center" rowspan="1" colspan="1">Type</th>
                    <th align="center" rowspan="1" colspan="1">AME refraction</th>
                    <th align="center" rowspan="1" colspan="1">FFE refraction</th>
                    <th align="center" rowspan="1" colspan="1">Strab</th>
                    <th align="center" rowspan="1" colspan="1">Stereo (arc/sec)</th>
                    <th align="center" rowspan="1" colspan="1">Suppression</th>
                    <th align="center" rowspan="1" colspan="1">History</th>
                    <th align="center" rowspan="1" colspan="1">BDNF</th>
                    <th align="center" rowspan="1" colspan="1">First treatment</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P1</td>
                    <td align="center" rowspan="1" colspan="1">43/F</td>
                    <td align="center" rowspan="1" colspan="1">1.00</td>
                    <td align="center" rowspan="1" colspan="1">0.00</td>
                    <td align="center" rowspan="1" colspan="1">Aniso</td>
                    <td align="center" rowspan="1" colspan="1">-0.25</td>
                    <td align="center" rowspan="1" colspan="1">+6.00/−2.25 × 180</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="center" rowspan="1" colspan="1">Nil</td>
                    <td align="center" rowspan="1" colspan="1">Full</td>
                    <td align="center" rowspan="1" colspan="1">Patching age 7</td>
                    <td align="center" rowspan="1" colspan="1">Val66Met</td>
                    <td align="center" rowspan="1" colspan="1">Placebo</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P2</td>
                    <td align="center" rowspan="1" colspan="1">32/M</td>
                    <td align="center" rowspan="1" colspan="1">1.20</td>
                    <td align="center" rowspan="1" colspan="1">-0.04</td>
                    <td align="center" rowspan="1" colspan="1">Mixed</td>
                    <td align="center" rowspan="1" colspan="1">+9.75</td>
                    <td align="center" rowspan="1" colspan="1">-0.25</td>
                    <td align="center" rowspan="1" colspan="1">Exo12<italic>Δ</italic>, hyper 11<italic>Δ</italic></td>
                    <td align="center" rowspan="1" colspan="1">Nil</td>
                    <td align="center" rowspan="1" colspan="1">Full</td>
                    <td align="center" rowspan="1" colspan="1">Surgery 14 yrs, patching and spectacles 10-12 yrs</td>
                    <td align="center" rowspan="1" colspan="1">Val/val</td>
                    <td align="center" rowspan="1" colspan="1">Active</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P3</td>
                    <td align="center" rowspan="1" colspan="1">47/M</td>
                    <td align="center" rowspan="1" colspan="1">0.64</td>
                    <td align="center" rowspan="1" colspan="1">-0.10</td>
                    <td align="center" rowspan="1" colspan="1">Mixed</td>
                    <td align="center" rowspan="1" colspan="1">Plano/−0.25 × 160</td>
                    <td align="center" rowspan="1" colspan="1">+1.75</td>
                    <td align="center" rowspan="1" colspan="1">Eso 10<italic>Δ</italic></td>
                    <td align="center" rowspan="1" colspan="1">Nil</td>
                    <td align="center" rowspan="1" colspan="1">Full</td>
                    <td align="center" rowspan="1" colspan="1">Surgery 7 yrs</td>
                    <td align="center" rowspan="1" colspan="1">Val/val</td>
                    <td align="center" rowspan="1" colspan="1">Placebo</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P4</td>
                    <td align="center" rowspan="1" colspan="1">19/F</td>
                    <td align="center" rowspan="1" colspan="1">0.34</td>
                    <td align="center" rowspan="1" colspan="1">-0.04</td>
                    <td align="center" rowspan="1" colspan="1">Aniso</td>
                    <td align="center" rowspan="1" colspan="1">+3.75/−1.75 × 180</td>
                    <td align="center" rowspan="1" colspan="1">+0.50/−0.25 × 180</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="center" rowspan="1" colspan="1">60</td>
                    <td align="center" rowspan="1" colspan="1">Intermittent</td>
                    <td align="center" rowspan="1" colspan="1">Detected 11 yrs patching and VT</td>
                    <td align="center" rowspan="1" colspan="1">Val66Met</td>
                    <td align="center" rowspan="1" colspan="1">Active</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P5</td>
                    <td align="center" rowspan="1" colspan="1">19/M</td>
                    <td align="center" rowspan="1" colspan="1">1.00</td>
                    <td align="center" rowspan="1" colspan="1">0.00</td>
                    <td align="center" rowspan="1" colspan="1">Strab</td>
                    <td align="center" rowspan="1" colspan="1">+4.50/−1.50 × 104</td>
                    <td align="center" rowspan="1" colspan="1">+3.50/−0.25 × 170</td>
                    <td align="center" rowspan="1" colspan="1">Eso 6<italic>Δ</italic></td>
                    <td align="center" rowspan="1" colspan="1">Nil</td>
                    <td align="center" rowspan="1" colspan="1">Full</td>
                    <td align="center" rowspan="1" colspan="1">Spectacles and patching in childhood</td>
                    <td align="center" rowspan="1" colspan="1">Val/val</td>
                    <td align="center" rowspan="1" colspan="1">Active</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P6</td>
                    <td align="center" rowspan="1" colspan="1">30/M</td>
                    <td align="center" rowspan="1" colspan="1">0.10</td>
                    <td align="center" rowspan="1" colspan="1">-0.08</td>
                    <td align="center" rowspan="1" colspan="1">Strab</td>
                    <td align="center" rowspan="1" colspan="1">Plano/−1.00 × 20</td>
                    <td align="center" rowspan="1" colspan="1">-2</td>
                    <td align="center" rowspan="1" colspan="1">Exo 20<italic>Δ</italic></td>
                    <td align="center" rowspan="1" colspan="1">Nil</td>
                    <td align="center" rowspan="1" colspan="1">Full</td>
                    <td align="center" rowspan="1" colspan="1">Surgery 2 yrs, patching in childhood</td>
                    <td align="center" rowspan="1" colspan="1">Val/val</td>
                    <td align="center" rowspan="1" colspan="1">Active</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P7</td>
                    <td align="center" rowspan="1" colspan="1">44/M</td>
                    <td align="center" rowspan="1" colspan="1">0.34</td>
                    <td align="center" rowspan="1" colspan="1">0.00</td>
                    <td align="center" rowspan="1" colspan="1">Mixed</td>
                    <td align="center" rowspan="1" colspan="1">+5.25/−1.25 × 90</td>
                    <td align="center" rowspan="1" colspan="1">+1.75/0.50 × 75</td>
                    <td align="center" rowspan="1" colspan="1">Exo 12<italic>Δ</italic></td>
                    <td align="center" rowspan="1" colspan="1">Nil</td>
                    <td align="center" rowspan="1" colspan="1">Full</td>
                    <td align="center" rowspan="1" colspan="1">Surgery 2 and 10 yrs, spectacles until 15 yrs old</td>
                    <td align="center" rowspan="1" colspan="1">Val/val</td>
                    <td align="center" rowspan="1" colspan="1">Active</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>AME: amblyopic eye; FFE: fellow fixing eye; VA: visual acuity; exo: exotropia; eso: esotropia; hyper: hypertropia; aniso: anisometropic; strab: strabismic/strabismus; VT: vision training; BDNF: brain-derived neurotrophic factor.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap id="tab2" orientation="portrait" position="float">
              <label>Table 2</label>
              <caption>
                <p>Amblyopic eye visual acuity results.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th rowspan="1" colspan="1"/>
                    <th align="center" rowspan="1" colspan="1">Active baseline</th>
                    <th align="center" rowspan="1" colspan="1">Active outcome</th>
                    <th align="center" rowspan="1" colspan="1">Active change</th>
                    <th align="center" rowspan="1" colspan="1">Placebo baseline</th>
                    <th align="center" rowspan="1" colspan="1">Placebo outcome</th>
                    <th align="center" rowspan="1" colspan="1">Placebo change</th>
                    <th align="center" rowspan="1" colspan="1">Final washout</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P1</td>
                    <td align="center" rowspan="1" colspan="1">0.94</td>
                    <td align="center" rowspan="1" colspan="1">0.82</td>
                    <td align="center" rowspan="1" colspan="1">0.12</td>
                    <td align="center" rowspan="1" colspan="1">1</td>
                    <td align="center" rowspan="1" colspan="1">0.97</td>
                    <td align="center" rowspan="1" colspan="1">0.03</td>
                    <td align="center" rowspan="1" colspan="1">0.87</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P2</td>
                    <td align="center" rowspan="1" colspan="1">1.20</td>
                    <td align="center" rowspan="1" colspan="1">1.20</td>
                    <td align="center" rowspan="1" colspan="1">0.00</td>
                    <td align="center" rowspan="1" colspan="1">1</td>
                    <td align="center" rowspan="1" colspan="1">1</td>
                    <td align="center" rowspan="1" colspan="1">0</td>
                    <td align="center" rowspan="1" colspan="1">1.1</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P3</td>
                    <td align="center" rowspan="1" colspan="1">0.73</td>
                    <td align="center" rowspan="1" colspan="1">0.60</td>
                    <td align="center" rowspan="1" colspan="1">0.13</td>
                    <td align="center" rowspan="1" colspan="1">0.64</td>
                    <td align="center" rowspan="1" colspan="1">0.67</td>
                    <td align="center" rowspan="1" colspan="1">-0.03</td>
                    <td align="center" rowspan="1" colspan="1">0.633</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P4</td>
                    <td align="center" rowspan="1" colspan="1">0.34</td>
                    <td align="center" rowspan="1" colspan="1">0.36</td>
                    <td align="center" rowspan="1" colspan="1">-0.02</td>
                    <td align="center" rowspan="1" colspan="1">0.32</td>
                    <td align="center" rowspan="1" colspan="1">0.32</td>
                    <td align="center" rowspan="1" colspan="1">0</td>
                    <td align="center" rowspan="1" colspan="1">0.3</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P5</td>
                    <td align="center" rowspan="1" colspan="1">1.00</td>
                    <td align="center" rowspan="1" colspan="1">0.60</td>
                    <td align="center" rowspan="1" colspan="1">0.40</td>
                    <td align="center" rowspan="1" colspan="1">0.866</td>
                    <td align="center" rowspan="1" colspan="1">0.9</td>
                    <td align="center" rowspan="1" colspan="1">-0.034</td>
                    <td align="center" rowspan="1" colspan="1">0.74</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P6</td>
                    <td align="center" rowspan="1" colspan="1">0.10</td>
                    <td align="center" rowspan="1" colspan="1">0.10</td>
                    <td align="center" rowspan="1" colspan="1">0.00</td>
                    <td align="center" rowspan="1" colspan="1">0.1</td>
                    <td align="center" rowspan="1" colspan="1">0.08</td>
                    <td align="center" rowspan="1" colspan="1">0.02</td>
                    <td align="center" rowspan="1" colspan="1">0.14</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P7</td>
                    <td align="center" rowspan="1" colspan="1">0.34</td>
                    <td align="center" rowspan="1" colspan="1">0.40</td>
                    <td align="center" rowspan="1" colspan="1">-0.06</td>
                    <td align="center" rowspan="1" colspan="1">0.32</td>
                    <td align="center" rowspan="1" colspan="1">0.36</td>
                    <td align="center" rowspan="1" colspan="1">-0.04</td>
                    <td align="center" rowspan="1" colspan="1">0.32</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Mean (SD)</td>
                    <td align="center" rowspan="1" colspan="1">
                      <bold>0.66 (0.36)</bold>
                    </td>
                    <td align="center" rowspan="1" colspan="1">
                      <bold>0.58 (0.35)</bold>
                    </td>
                    <td align="center" rowspan="1" colspan="1">
                      <bold>0.08 (0.16)</bold>
                    </td>
                    <td align="center" rowspan="1" colspan="1">
                      <bold>0.61 (0.36)</bold>
                    </td>
                    <td align="center" rowspan="1" colspan="1">
                      <bold>0.61 (0.36)</bold>
                    </td>
                    <td align="center" rowspan="1" colspan="1">
                      <bold>-0.01 (0.03)</bold>
                    </td>
                    <td align="center" rowspan="1" colspan="1">
                      <bold>0.59 (0.35)</bold>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Change values were calculated by subtracting the outcome from the baseline. All values are in logMAR.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap id="tab3" orientation="portrait" position="float">
              <label>Table 3</label>
              <caption>
                <p>Self-reported patching adherence data sourced from participants' patching diaries.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th rowspan="1" colspan="1"/>
                    <th align="center" rowspan="1" colspan="1">Active</th>
                    <th align="center" rowspan="1" colspan="1">Placebo</th>
                    <th align="center" rowspan="1" colspan="1">Difference</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P1</td>
                    <td align="center" rowspan="1" colspan="1">116 (31)</td>
                    <td align="center" rowspan="1" colspan="1">114 (24)</td>
                    <td align="center" rowspan="1" colspan="1">2</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P2</td>
                    <td align="center" rowspan="1" colspan="1">40 (19)</td>
                    <td align="center" rowspan="1" colspan="1">29 (21)</td>
                    <td align="center" rowspan="1" colspan="1">11</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P3</td>
                    <td align="center" rowspan="1" colspan="1">55 (28)</td>
                    <td align="center" rowspan="1" colspan="1">55 (7)</td>
                    <td align="center" rowspan="1" colspan="1">1</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P4</td>
                    <td align="center" rowspan="1" colspan="1">96 (38)</td>
                    <td align="center" rowspan="1" colspan="1">111 (32)</td>
                    <td align="center" rowspan="1" colspan="1">-15</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P5</td>
                    <td align="center" rowspan="1" colspan="1">75 (0)</td>
                    <td align="center" rowspan="1" colspan="1">75 (0)</td>
                    <td align="center" rowspan="1" colspan="1">0</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P6</td>
                    <td align="center" rowspan="1" colspan="1">111 (78)</td>
                    <td align="center" rowspan="1" colspan="1">111 (74)</td>
                    <td align="center" rowspan="1" colspan="1">0</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">P7</td>
                    <td align="center" rowspan="1" colspan="1">111 (32)</td>
                    <td align="center" rowspan="1" colspan="1">111 (32)</td>
                    <td align="center" rowspan="1" colspan="1">0</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">Mean (SD)</td>
                    <td align="center" rowspan="1" colspan="1">
                      <bold>86 (30)</bold>
                    </td>
                    <td align="center" rowspan="1" colspan="1">
                      <bold>87 (34)</bold>
                    </td>
                    <td align="center" rowspan="1" colspan="1">
                      <bold>0.1 (7.6)</bold>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Data are shown as mean minutes of patching per day (SD). The prescribed dose was 120 minutes per day.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
